ImmunoPrecise Begins Path to NASDAQ

This morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to dual list their stock on the NASDAQ. In the news release, the company states they believe the move will gain greater exposure for the company to access a larger base of retail and institutional investors in the United States and internationally.

ImmunoPrecise Antibodies Ltd. Logo (CNW Group/ImmunoPrecise Antibodies Ltd.)

ImmunoPrecise is a full-service, therapeutic antibody discovery company utilizing species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe. IPA has developed a technology platform with end-to-end solutions empowering companies to discover and develop therapies against any disease. Their full-service capabilities reduce the time and risk associated with conventional multi-vendor product development.

The company has been working on COVID by identifying antibodies derived from multiple species (human, llama, Ligand’s humanized OmniRat, and wild-type rabbits) which demonstrate potent, in vitro neutralizing activity. They have discovered their functional antibodies using the Company’s DeepDisplay phage technology, B Cell Select and Single Step Hybridoma platforms.

At the time of publishing IPA stock is trading at $1.85 an increase of 3.9%.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Information for this analysis was found via Sedar and ImmunoPrecise Antibodies Ltd. The author is long common shares of ImmunoPrecise Antibodies (IPA.v). Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Mask Mandates Return as Rate of Hospitalization Increases in the US

Morris Brown College, a private Atlanta institution, has reissued a face mask mandate for its...

Wednesday, August 23, 2023, 02:09:00 PM

Feds Investigate $120,000 Jury Bribery Attempt in Major COVID-19 Relief Fraud Case

Federal authorities in Minnesota have confiscated cellphones and taken all seven defendants into custody as...

Wednesday, June 5, 2024, 11:40:00 AM

Denmark to Begin Offering Covid-19 ‘Vaccine Passport’ for Travelers in Early 2021

As the coronavirus pandemic continues to spiral out of control and decimate air travel around...

Thursday, January 14, 2021, 04:01:00 PM

Market Movers: Canadian Small Cap COVID-19 Stocks Take A Beating

COVID-19 related stocks are all the rage this morning, however it appears to be for...

Monday, November 9, 2020, 10:56:07 AM

Struggling US Retailers Owe $52 Billion in Overdue Rent

The coronavirus pandemic has turned consumerism right on its head with its strict social distancing...

Thursday, November 26, 2020, 10:30:00 AM